Venture Certified
| 벤처투자유형 | 2018-08-09 ~ 2020-08-08 | 20180300548 | 2018-08-09 |
| 벤처투자유형 | 2020-08-09 ~ 2022-08-08 | 20200300911 | 2018-08-09 |
| 벤처투자유형 | 2022-08-09 ~ 2025-08-08 | 20220803010039 | 2018-08-09 |
| 벤처투자유형 | 2025-08-09 ~ 2028-08-08 | 20250806010019 | 2018-08-09 |
| Name | Position | Role |
|---|---|---|
| 김흥재 | 대표이사 | 대표 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 티오우레아 유도체를 포함하는 섬유화 질환의 예방 또는 치료용 조성물 | (주)테라시드바이오사이언스 | 1020220056757 | 2022-05-09 | 등록 |
| 1-(4-벤질옥시-벤질)-3-메틸-티오우레아의 신규 결정형의 제조 방법 | (주)테라시드바이오사이언스 | 1020227017709 | 2020-11-16 | 포기 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 용인시",
"ceo_name": "김흥재",
"certificate": [
{
"cert_number": "20180300548",
"changes": "",
"disclosure_date": "2018-08-09",
"first_cert_date": "2018-08-09",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2018-08-09 ~ 2020-08-08"
},
{
"cert_number": "20200300911",
"changes": "",
"disclosure_date": "2020-08-13",
"first_cert_date": "2018-08-09",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2020-08-09 ~ 2022-08-08"
},
{
"cert_number": "20220803010039",
"changes": "",
"disclosure_date": "2022-08-03",
"first_cert_date": "2018-08-09",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2022-08-09 ~ 2025-08-08"
},
{
"cert_number": "20250806010019",
"changes": "소재지",
"disclosure_date": "2025-08-06",
"first_cert_date": "2018-08-09",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2025-08-09 ~ 2028-08-08"
}
],
"company_name": "(주)테라시드바이오사이언스",
"corp_no": "131111-*******",
"financials": {},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "586,605,500",
"changes": "586,605,500",
"date": "2022-06-23"
},
{
"amount": "4,500,000,000",
"changes": "4,500,000,000",
"date": "2022-05-19"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2022-05-19"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2022-05-19"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2022-05-19"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2022-05-19"
},
{
"amount": "405,356,000",
"changes": "405,356,000",
"date": "2019-06-20"
},
{
"amount": "999,999,000",
"changes": "999,999,000",
"date": "2019-06-20"
}
],
"main_products": "NASH 치료제 개발",
"phone": "031-707-****",
"years": []
}Data Quality: 3/10 | Primary Source: Venture System | Section Coverage: 5/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Not Collected | Not Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| KIPRIS Patents | 2026-02-28 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |